Tasigna 200mg Capsule
Prescription Required
Product introduction
Tasigna 200mg Capsule is used in the treatment of blood cancer (chronic myeloid leukaemia). It is used in patients whose disease could not be treated with other medications for leukaemia or who cannot take these medications because of side effects.
Tasigna 200mg Capsule is used to treat different types of cancer
Tasigna 200mg Capsule is used to treat different types of cancer
Uses of Tasigna Capsule
Benefits of Tasigna Capsule
In Blood cancer (Chronic myeloid leukaemia)
Blood cancer, also called leukemia, is a cancer of the blood-forming tissues, that decreases the body's ability to fight infection. Tasigna 200mg Capsule kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated.
Side effects of Tasigna Capsule
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Tasigna
- Headache
- Nausea
- Abdominal pain
- Rash
- Itching
- Hair loss
- Muscle pain
- Fatigue
How to use Tasigna Capsule
Take this medicine in the dose and duration as advised by your doctor. Tasigna 200mg Capsule is to be taken empty stomach.
Safety advice
Alcohol
SAFE
Consuming alcohol with Tasigna 200mg Capsule does not cause any harmful side effects.
Pregnancy
CONSULT YOUR DOCTOR
Tasigna 200mg Capsule is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding
UNSAFE
Tasigna 200mg Capsule is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving
UNSAFE
Tasigna 200mg Capsule may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney
SAFE IF PRESCRIBED
Tasigna 200mg Capsule is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Tasigna 200mg Capsule may not be needed in these patients. Please consult your doctor.
Liver
CAUTION
Tasigna 200mg Capsule should be used with caution in patients with liver disease. Dose adjustment of Tasigna 200mg Capsule may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Fact Box
Chemical Class
Aminopyrimidine Derivative
Habit Forming
No
Therapeutic Class
ANTI NEOPLASTICS
Action Class
Tyrosine kinase inhibitors
Patient concerns
User feedback
What are you using Tasigna Capsule for?
Blood cancer *
100%
*Blood cancer (Chronic myeloid leukaemia)
How much was the improvement?
Excellent
67%
Average
33%
What were the side-effects while using Tasigna 200mg Capsule?
Headache
100%
How do you take Tasigna Capsule?
Empty stomach
100%
Please rate Tasigna 200mg Capsule on price
Expensive
100%
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1732-34.
- Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 953.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 980-82.
- Medscape. Nilotinib. [Accessed 26 Mar. 2019] (online) Available from:
- Novartis.com. Nilotinib. [Accessed 26 Mar. 2019] (online) Available from:
Marketer details
Name: Novartis India Ltd
Address: Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
480 people viewed this recentlyMRP
₹8507.57
Inclusive of all taxes
4.0 capsules in 1 strip
SOLD OUT
Notify me